Skip to content
PubMed This is a summary of 89 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 89 referenced papers

Top Authors

Andrew Richard Gennery
Great North Children's Hospital
Arjan C. Lankester
Leiden University Medical Center
Jean‐Laurent Casanova
Hôpital Necker-Enfants Malades
Bénédicte Neven
Hôpital Necker-Enfants Malades
Emma C. Morris
University College London Hospitals NHS Foundation Trust
Luigi Daniele Notarangelo
National Institutes of Health
Mary Anne Slatter
Great North Children's Hospital
Despina Moshous
Hôpital Necker-Enfants Malades
Kai Lehmberg
University Medical Center Hamburg-Eppendorf
Paul A. Veys
Great Ormond Street Hospital

Top Institutions

Ranked by publications Top 10 institutions
04

References

References (89)
  1. 1

    Itk signals promote neuroinflammation by regulating CD4+ T-cell activation and trafficking.

    Kannan AK, Kim DG, August A, Bynoe MS

    The Journal of neuroscience : the official journal of the Society for Neuroscience 2015; (35(1)):221-33 doi:10.1523/JNEUROSCI.1957-14.2015.

    PMID: 25568116
  2. 2

    High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency.

    Bienemann K, Borkhardt A, Klapper W, Oschlies I

    Histopathology 2015; (67(5)):607-16 doi:10.1111/his.12677.

    PMID: 25728094
  3. 3

    Novel mutations in TNFRSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency.

    Alkhairy OK, Perez-Becker R, Driessen GJ, et al.

    The Journal of allergy and clinical immunology 2015; (136(3)):703-712.e10.

    PMID: 25843314
  4. 4

    Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency.

    Scarselli A, Di Cesare S, Capponi C, et al.

    Journal of clinical immunology 2015; (35(4)):373-83 doi:10.1007/s10875-015-0154-4.

    PMID: 25875698
  5. 5

    Allele-sensitive mutant, Itkas, reveals that Itk kinase activity is required for Th1, Th2, Th17, and iNKT-cell cytokine production.

    Kannan A, Lee Y, Qi Q, et al.

    European journal of immunology 2015; (45(8)):2276-85 doi:10.1002/eji.201445087.

    PMID: 25989458
  6. 6

    Atypical Clinical Course in Pediatric Hodgkin Lymphoma: Association With Germline Mutations in Interleukin-2-inducible T-Cell Kinase.

    Alme C, Satwani P, Alobeid B, et al.

    Journal of pediatric hematology/oncology 2015; (37(7)):507-8 doi:10.1097/MPH.0000000000000366.

    PMID: 26056787
  7. 7

    Different Aspects of Psychological Ill Health in a National Sample of Swedish Parents after Successful Paediatric Stem Cell Transplantation.

    Norberg AL, Forinder U

    Pediatric blood & cancer 2016; (63(6)):1065-9 doi:10.1002/pbc.25908.

    PMID: 26785348
  8. 8

    An overview of infectious complications after allogeneic hematopoietic stem cell transplantation.

    Sahin U, Toprak SK, Atilla PA, et al.

    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2016; (22(8)):505-14.

    PMID: 27344206
  9. 9

    Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines.

    Styczynski J, van der Velden W, Fox CP, et al.

    Haematologica 2016; (101(7)):803-11 doi:10.3324/haematol.2016.144428.

    PMID: 27365460
  10. 10

    Risk of hemophagocytic lymphohistiocytosis in adults with fevers of unknown origin: the clinical utility of a new scoring system on early detection.

    Wang HY, Yang CF, Chiou TJ, et al.

    Hematological oncology 2017; (35(4)):835-844 doi:10.1002/hon.2333.

    PMID: 27465587
  11. 11

    Group-Based Trajectory Modeling of Distress and Well-Being Among Caregivers of Children Undergoing Hematopoetic Stem Cell Transplant.

    Sands SA, Mee L, Bartell A, et al.

    Journal of pediatric psychology 2017; (42(3)):283-295 doi:10.1093/jpepsy/jsw064.

    PMID: 27543915
  12. 12

    Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection.

    Izawa K, Martin E, Soudais C, et al.

    The Journal of experimental medicine 2017; (214(1)):73-89 doi:10.1084/jem.20160784.

    PMID: 28011863
  13. 13

    Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency.

    Abolhassani H, Edwards ES, Ikinciogullari A, et al.

    The Journal of experimental medicine 2017; (214(1)):91-106 doi:10.1084/jem.20160849.

    PMID: 28011864
  14. 14

    Inducible T Cell Kinase Regulates the Acquisition of Cytolytic Capacity and Degranulation in CD8+ CTLs.

    Kapnick SM, Stinchcombe JC, Griffiths GM, Schwartzberg PL

    Journal of immunology (Baltimore, Md. : 1950) 2017; (198(7)):2699-2711 doi:10.4049/jimmunol.1601202.

    PMID: 28213500
  15. 15

    Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.

    Abdel-Azim H, Elshoury A, Mahadeo KM, et al.

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2017; (23(9)):1437-1446 doi:10.1016/j.bbmt.2017.05.005.

    PMID: 28495643
  16. 16

    A PLC-γ1 Feedback Pathway Regulates Lck Substrate Phosphorylation at the T-Cell Receptor and SLP-76 Complex.

    Belmont J, Gu T, Mudd A, Salomon AR

    Journal of proteome research 2017; (16(8)):2729-2742 doi:10.1021/acs.jproteome.6b01026.

    PMID: 28644030
  17. 17

    Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations.

    Miot C, Imai K, Imai C, et al.

    Blood 2017; (130(12)):1456-1467 doi:10.1182/blood-2017-03-771600.

    PMID: 28679735
  18. 18

    T-cell receptor αβ+ and CD19+ cell-depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency.

    Shah RM, Elfeky R, Nademi Z, et al.

    The Journal of allergy and clinical immunology 2018; (141(4)):1417-1426.e1 doi:10.1016/j.jaci.2017.07.008.

    PMID: 28780238
  19. 19

    Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study.

    Bergsten E, Horne A, Aricó M, et al.

    Blood 2017; (130(25)):2728-2738 doi:10.1182/blood-2017-06-788349.

    PMID: 28935695
  20. 20

    Multidomain Control Over TEC Kinase Activation State Tunes the T Cell Response.

    Andreotti AH, Joseph RE, Conley JM, et al.

    Annual review of immunology 2018; (36()):549-578 doi:10.1146/annurev-immunol-042617-053344.

    PMID: 29677469
  21. 21

    Initial Characteristics and Clinical Severity of Hemophagocytic Lymphohistiocytosis in Pediatric Patients Admitted in the Emergency Department.

    Lee JY, Kim JH, Lee JS, et al.

    Pediatric emergency care 2021; (37(4)):204-207 doi:10.1097/PEC.0000000000001518.

    PMID: 29794953
  22. 22

    Interleukin-2-Inducible T-Cell Kinase Deficiency-New Patients, New Insight?

    Ghosh S, Drexler I, Bhatia S, et al.

    Frontiers in immunology 2018; (9()):979 doi:10.3389/fimmu.2018.00979.

    PMID: 29867957
  23. 23

    SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.

    Haddad E, Logan BR, Griffith LM, et al.

    Blood 2018; (132(17)):1737-1749 doi:10.1182/blood-2018-03-840702.

    PMID: 30154114
  24. 24

    TCR αβ+/CD19+ cell depletion in haploidentical hematopoietic allogeneic stem cell transplantation: a review of current data.

    Sahasrabudhe K, Otto M, Hematti P, Kenkre V

    Leukemia & lymphoma 2019; (60(3)):598-609 doi:10.1080/10428194.2018.1485905.

    PMID: 30187806
  25. 25

    Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency Disorders: Experience from a Referral Center in India.

    Uppuluri R, Jayaraman D, Sivasankaran M, et al.

    Indian pediatrics 2018; (55(8)):661-664.

    PMID: 30218511
  26. 26

    [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].

    Chen TM, Deng ZJ, Hu B, et al.

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2018; (56(10)):759-764 doi:10.3760/cma.j.issn.0578-1310.2018.10.008.

    PMID: 30293280
  27. 27

    Management of XLP-1 and ITK deficiency: The challenges posed by PID with an unpredictable spectrum of disease manifestations.

    Shadur B, Abuzaitoun O, NaserEddin A, et al.

    Clinical immunology (Orlando, Fla.) 2019; (198()):39-45 doi:10.1016/j.clim.2018.12.016.

    PMID: 30572125
  28. 28

    Inherited Interleukin 2-Inducible T-Cell (ITK) Kinase Deficiency in Siblings With Epidermodysplasia Verruciformis and Hodgkin Lymphoma.

    Youssefian L, Vahidnezhad H, Yousefi M, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019; (68(11)):1938-1941 doi:10.1093/cid/ciy942.

    PMID: 30778533
  29. 29

    Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019.

    Duarte RF, Labopin M, Bader P, et al.

    Bone marrow transplantation 2019; (54(10)):1525-1552 doi:10.1038/s41409-019-0516-2.

    PMID: 30953028
  30. 30

    Genetic Deficiency and Biochemical Inhibition of ITK Affect Human Th17, Treg, and Innate Lymphoid Cells.

    Eken A, Cansever M, Somekh I, et al.

    Journal of clinical immunology 2019; (39(4)):391-400 doi:10.1007/s10875-019-00632-5.

    PMID: 31025232
  31. 31

    Use of TCR α+β+/CD19+-Depleted Haploidentical Hematopoietic Stem Cell Transplant Is a Viable Option in Patients With Primary Immune Deficiency Without Matched Sibling Donor.

    Brettig T, Smart J, Choo S, et al.

    Journal of clinical immunology 2019; (39(5)):505-511 doi:10.1007/s10875-019-00648-x.

    PMID: 31172381
  32. 32

    Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.

    Latour S, Fischer A

    Immunological reviews 2019; (291(1)):174-189 doi:10.1111/imr.12791.

    PMID: 31402499
  33. 33

    Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives.

    Castagnoli R, Delmonte OM, Calzoni E, Notarangelo LD

    Frontiers in pediatrics 2019; (7()):295 doi:10.3389/fped.2019.00295.

    PMID: 31440487
  34. 34

    Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases.

    Dimitrova D, Gea-Banacloche J, Steinberg SM, et al.

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2020; (26(1)):94-106 doi:10.1016/j.bbmt.2019.08.018.

    PMID: 31493539
  35. 35

    Magnesium Restores Activity to Peripheral Blood Cells in a Patient With Functionally Impaired Interleukin-2-Inducible T Cell Kinase.

    Howe MK, Dowdell K, Roy A, et al.

    Frontiers in immunology 2019; (10()):2000 doi:10.3389/fimmu.2019.02000.

    PMID: 31507602
  36. 36

    Mismatched related vs matched unrelated donors in TCRαβ/CD19-depleted HSCT for primary immunodeficiencies.

    Laberko A, Sultanova E, Gutovskaya E, et al.

    Blood 2019; (134(20)):1755-1763 doi:10.1182/blood.2019001757.

    PMID: 31558465
  37. 37

    Primary immunodeficiency disease: a retrospective study of 112 Chinese children in a single tertiary care center.

    Wu J, Zhong W, Yin Y, Zhang H

    BMC pediatrics 2019; (19(1)):410 doi:10.1186/s12887-019-1729-7.

    PMID: 31684895
  38. 38

    Epstein-Barr virus related post-transplant lymphoproliferative disorder prevention strategies in allogeneic hematopoietic stem cell transplantation.

    Lindsay J, Yong MK, Greenwood M, et al.

    Reviews in medical virology 2020; (30(4)):e2108 doi:10.1002/rmv.2108.

    PMID: 32301566
  39. 39

    Information and Emotional Support Needs of Families Whose Infant Was Diagnosed With SCID Through Newborn Screening.

    Raspa M, Lynch M, Squiers L, et al.

    Frontiers in immunology 2020; (11()):885 doi:10.3389/fimmu.2020.00885.

    PMID: 32435251
  40. 40

    X-Linked Lymphoproliferative Disease in Latvia: A Report of Two Clinically Distinct Cases.

    Nokalna I, Kreile M, Butane D, et al.

    Case reports in medicine 2020; (2020()):7108657 doi:10.1155/2020/7108657.

    PMID: 32774386
  41. 41

    Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: results from the HLH-2004 study.

    Bergsten E, Horne A, Hed Myrberg I, et al.

    Blood advances 2020; (4(15)):3754-3766 doi:10.1182/bloodadvances.2020002101.

    PMID: 32780845
  42. 42

    Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis.

    Lechner KS, Neurath MF, Weigmann B

    Journal of molecular medicine (Berlin, Germany) 2020; (98(10)):1385-1395 doi:10.1007/s00109-020-01958-z.

    PMID: 32808093
  43. 43

    Parents' Perspectives and Societal Acceptance of Implementation of Newborn Screening for SCID in the Netherlands.

    Blom M, Bredius RGM, Jansen ME, et al.

    Journal of clinical immunology 2021; (41(1)):99-108 doi:10.1007/s10875-020-00886-4.

    PMID: 33070266
  44. 44

    Itk Promotes the Integration of TCR and CD28 Costimulation through Its Direct Substrates SLP-76 and Gads.

    Hallumi E, Shalah R, Lo WL, et al.

    Journal of immunology (Baltimore, Md. : 1950) 2021; (206(10)):2322-2337 doi:10.4049/jimmunol.2001053.

    PMID: 33931484
  45. 45

    Natural History of Epstein-Barr Virus Replication and Viral Load Dynamics after Alemtuzumab-Based Allogeneic Stem Cell Transplantation.

    Marzolini MAV, Wilson AJ, Sanchez E, et al.

    Transplantation and cellular therapy 2021; (27(8)):682.e1-682.e12 doi:10.1016/j.jtct.2021.04.020.

    PMID: 33962069
  46. 46

    How I use allogeneic HSCT for adults with inborn errors of immunity.

    Burns SO, Morris EC

    Blood 2021; (138(18)):1666-1676 doi:10.1182/blood.2020008187.

    PMID: 34077952
  47. 47

    Transition from Acute Treatment to Survivorship: Exploring the Psychosocial Adjustments of Chinese Parents of Children with Cancer or Hematological Disorders.

    Yeung NCY, Cheung KC, Chau HC, et al.

    International journal of environmental research and public health 2021; (18(15)) doi:10.3390/ijerph18157815.

    PMID: 34360108
  48. 48

    Hierarchy of signaling thresholds downstream of the T cell receptor and the Tec kinase ITK.

    Gallagher MP, Conley JM, Vangala P, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2021; (118(35)) doi:10.1073/pnas.2025825118.

    PMID: 34452995
  49. 49

    Screening of hemophagocytic lymphohistiocytosis in children with severe sepsis in pediatric intensive care.

    El-Sayed ZA, El-Owaidy RH, Khamis MA, Rezk AR

    Science progress 2021; (104(3)):368504211044042 doi:10.1177/00368504211044042.

    PMID: 34519554
  50. 50

    Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency.

    Yang L, Booth C, Speckmann C, et al.

    The Journal of allergy and clinical immunology 2022; (150(2)):456-466 doi:10.1016/j.jaci.2021.10.037.

    PMID: 34920033
  51. 51

    T-replete HLA-matched grafts vs T-depleted HLA-mismatched grafts in inborn errors of immunity.

    Lum SH, Greener S, Perez-Heras I, et al.

    Blood advances 2022; (6(4)):1319-1328 doi:10.1182/bloodadvances.2020004072.

    PMID: 34972212
  52. 52

    Exon skipping caused by a complex structural variation in SH2D1A resulted in X-linked lymphoproliferative syndrome type 1.

    Wu L, Yang F, Wang J, et al.

    Molecular genetics & genomic medicine 2022; (10(3)):e1873 doi:10.1002/mgg3.1873.

    PMID: 35092357
  53. 53

    Retrospective, Landmark Analysis of Long-term Adult Morbidity Following Allogeneic HSCT for Inborn Errors of Immunity in Infancy and Childhood.

    Day JW, Elfeky R, Nicholson B, et al.

    Journal of clinical immunology 2022; (42(6)):1230-1243 doi:10.1007/s10875-022-01278-6.

    PMID: 35579633
  54. 54

    How to recognize inborn errors of immunity in a child presenting with a malignancy: guidelines for the pediatric hemato-oncologist.

    Bosch JVWT, Hlaváčková E, Derpoorter C, et al.

    Pediatric hematology and oncology 2023; (40(2)):131-146 doi:10.1080/08880018.2022.2085830.

    PMID: 35913104
  55. 55

    Impact of cytomegalovirus infection prior to hematopoietic stem cell transplantation in children with inborn errors of immunity.

    Del Rosal T, Quintana-Ortega C, Deyá-Martinez A, et al.

    European journal of pediatrics 2022; (181(11)):3889-3898 doi:10.1007/s00431-022-04614-5.

    PMID: 36102997
  56. 56

    A great disturbance in the force: IL-2 receptor defects disrupt immune homeostasis.

    Hernandez JD, Hsieh EWY

    Current opinion in pediatrics 2022; (34(6)):580-588 doi:10.1097/MOP.0000000000001181.

    PMID: 36165614
  57. 57

    Inherited human ITK deficiency impairs IFN-γ immunity and underlies tuberculosis.

    Ogishi M, Yang R, Rodriguez R, et al.

    The Journal of experimental medicine 2023; (220(1)) doi:10.1084/jem.20220484.

    PMID: 36326697
  58. 58

    Uncertainties experienced by parents of children diagnosed with severe combined immunodeficiency through newborn screening.

    Raspa M, Kutsa O, Andrews SM, et al.

    European journal of human genetics : EJHG 2024; (32(4)):392-398 doi:10.1038/s41431-023-01345-5.

    PMID: 36973394
  59. 59

    Inborn Errors of Immunity.

    Baloh CH, Chong H

    Primary care 2023; (50(2)):253-268 doi:10.1016/j.pop.2022.12.001.

    PMID: 37105605
  60. 60

    Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors.

    Bonifacius A, Lamottke B, Tischer-Zimmermann S, et al.

    The Journal of clinical investigation 2023; (133(12)).

    PMID: 37159273
  61. 61

    Case report: Multiple epstein-barr virus-associated smooth muscle tumours in a child with IL-2-inducible T-cell kinase mutation of undetermined clinical significance.

    Wen Q, Ning J, Mao Z, et al.

    Frontiers in pediatrics 2023; (11()):1189219 doi:10.3389/fped.2023.1189219.

    PMID: 37465420
  62. 62

    Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis.

    Ge J, Zhang Q, Ma H, et al.

    Haematologica 2024; (109(2)):458-465 doi:10.3324/haematol.2023.283478.

    PMID: 37470145
  63. 63

    Long-term parental distress after pediatric hematopoietic stem cell transplantation for nonmalignant diseases.

    Bense JE, Stiggelbout AM, Lankester AC, de Pagter APJ

    Pediatric blood & cancer 2023; (70(11)):e30638 doi:10.1002/pbc.30638.

    PMID: 37638835
  64. 64

    Pre-Emptive Use of Rituximab in Epstein-Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes.

    Papalexandri A, Gavriilaki E, Vardi A, et al.

    International journal of molecular sciences 2023; (24(22)) doi:10.3390/ijms242216029.

    PMID: 38003218
  65. 65

    Inflamed-HLH, MAS, or something else?

    Kumar A, Cournoyer E, Naymagon L

    Hematology. American Society of Hematology. Education Program 2023; (2023(1)):31-36 doi:10.1182/hematology.2023000463.

    PMID: 38066877
  66. 66

    Parental Engagement in Identifying Information Needs After Newborn Screening for Families of Infants with Suspected Athymia.

    Howley E, Soomann M, Kreins AY

    Journal of clinical immunology 2024; (44(3)):79 doi:10.1007/s10875-024-01678-w.

    PMID: 38457046
  67. 67

    Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity.

    Lum SH, Albert MH, Gilbert P, et al.

    Blood 2024; (144(5)):565-580 doi:10.1182/blood.2024024038.

    PMID: 38669631
  68. 68

    Epstein-Barr Virus Monitoring after an Allogeneic Hematopoietic Stem Cell Transplant: Review of the Recent Data and Current Practices in Canada.

    Ratiu C, Dufresne SF, Thiant S, Roy J

    Current oncology (Toronto, Ont.) 2024; (31(5)):2780-2795 doi:10.3390/curroncol31050211.

    PMID: 38785492
  69. 69

    The kinase ITK controls a Ca2+-mediated switch that balances TH17 and Treg cell differentiation.

    Anannya O, Huang W, August A

    Science signaling 2024; (17(846)):eadh2381 doi:10.1126/scisignal.adh2381.

    PMID: 39042726
  70. 70

    Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited.

    Henter JI, Sieni E, Eriksson J, et al.

    Blood 2024; (144(22)):2308-2318 doi:10.1182/blood.2024025077.

    PMID: 39046779
  71. 71

    Epstein-Barr virus-driven lymphoproliferation in inborn errors of immunity: a diagnostic and therapeutic challenge.

    Barman P, Basu S, Goyal T, et al.

    Expert review of clinical immunology 2024; (20(11)):1331-1346 doi:10.1080/1744666X.2024.2386427.

    PMID: 39066572
  72. 72

    Diagnostic tests for primary immunodeficiency disorders: Classic and genetic testing.

    Klangkalya N, Fleisher TA, Rosenzweig SD

    Allergy and asthma proceedings 2024; (45(5)):355-363 doi:10.2500/aap.2024.45.240051.

    PMID: 39294902
  73. 73

    Multiple Tumors in a Patient with Interleukin-2-Inducible T-Cell Kinase Deficiency: A Case Report.

    Di Filippo M, Tallone R, Muraca M, et al.

    International journal of molecular sciences 2024; (25(23)) doi:10.3390/ijms252313181.

    PMID: 39684891
  74. 74

    Haploidentical hematopoietic stem cell transplantation using post-transplant cyclophosphamide in patients with inborn errors of immunity: Experience in a reference center in Colombia

    Medina D, Castro JO, Castro DE, et al.

    Biomedica : revista del Instituto Nacional de Salud 2024; (44(Sp. 2)):118-130 doi:10.7705/biomedica.7560.

    PMID: 39836841
  75. 75

    Insights into the Absence of Lymphoma Despite Fulminant Epstein-Barr Virus Infection in Patients with XIAP Deficiency.

    Sun Y, Chou J, Dong K, et al.

    bioRxiv : the preprint server for biology 2025; doi:10.1101/2025.01.17.633616.

    PMID: 39868266
  76. 76

    Problem-Solving Skills Training for Parents of Children Undergoing Hematopoietic Stem Cell Transplantation: A Mixed Methods Feasibility Study.

    Bemis H, Ritter M, Lee MN, et al.

    Cancers 2025; (17(6)) doi:10.3390/cancers17060930.

    PMID: 40149268
  77. 77

    Inborn Errors of Immunity in Pediatric Hematology and Oncology: Diagnostic Principles for Clinical Practice.

    Roberti G, Maestrini G, Polito B, et al.

    Journal of clinical medicine 2025; (14(17)) doi:10.3390/jcm14176295.

    PMID: 40944054
  78. 78

    Epstein-Barr Virus-Associated Smooth Muscle Tumors in inborn Errors of Immunity: A single-center Case Series and Literature Overview.

    Aliyeva G, Bajin IY, Orhan D, et al.

    Journal of clinical immunology 2025; (45(1)):144.

    PMID: 41099879
  79. 79

    Rubella-associated granuloma in a patient with a compound heterozygous RAG1 defect and review of the literature.

    Akarsu A, Sonmez G, Schiefer AI, et al.

    Immunologic research 2025; (73(1)):150 doi:10.1007/s12026-025-09711-9.

    PMID: 41139764
  80. 80

    Pediatric hemophagocytic lymphohistiocytosis: current conceptualization, diagnosis, and treatment.

    Verkamp B, Jordan MB, Allen CE

    Blood 2026; (147(10)):1019-1036 doi:10.1182/blood.2025028762.

    PMID: 41481377
  81. 81

    Distinct EBV-Associated Phenotypes Due to a Novel Homozygous Missense Variant in CD27.

    Yang R, Turunbedu SK, Nandiwada S, et al.

    bioRxiv : the preprint server for biology 2026; doi:10.64898/2026.01.15.698722.

    PMID: 41607518
  82. 82

    αβT/CD19-depleted Allogeneic Stem Cell Transplantation in Adults with Inborn Errors of Immunity.

    de Winter JJH, Ibrahimov BM, Verheij FA, et al.

    Journal of clinical immunology 2026; (46(1)):21 doi:10.1007/s10875-025-01978-9.

    PMID: 41634270
  83. 83

    From T-cell defect to tumorigenesis: Epstein-Barr virus-associated smooth muscle tumors in ITK deficiency.

    Oussama K, Idrissi Fawzi F, Benhsaien I, et al.

    Clinical and experimental immunology 2026; (220(1)) doi:10.1093/cei/uxag028.

    PMID: 42132280
  84. 84

    Clinical experience with emapalumab treatment in a group of children with primary hemophagocytic lymphohistiocytosis.

    Rodina Y, Burlakov V, Brilliantova V, et al.

    Journal of human immunity 2026; (2(1)):e20250122 doi:10.70962/jhi.20250122.

    PMID: 42170590
  85. 85

    [Clinical and immunological evaluation of patients with inborn errors of immunity after hematopoietic cell transplantation].

    Llarens A, Cabanillas D, Tejada MP, et al.

    Archivos argentinos de pediatria 2026; (124(5)):e202611024 doi:10.5546/aap.2026-11024.

    PMID: 42189513
  86. 86

    Secondary hemophagocytic lymphohistiocytosis in pediatric patients: a single-center experience.

    Abu Shanap M, Bzour A, Sultan I, Rihani R

    Frontiers in pediatrics 2026; (14()):1834746 doi:10.3389/fped.2026.1834746.

    PMID: 42368290
  87. 87

    Immune Reconstitution After Hematopoietic Stem Cell Transplantation: Cellular Dynamics, Clinical Determinants, and Emerging Therapeutic Strategies.

    Elmansorry E

    Immunological investigations 2026; 1-31 doi:10.1080/08820139.2026.2696004.

    PMID: 42384545
  88. 88

    Multidisciplinary approach to early identification of inborn errors of immunity in patients with lymphoproliferation.

    Alsina L, Celis Passini V, Garrido Colino C, et al.

    Leukemia & lymphoma 2026; (67(11)):2192-2205 doi:10.1080/10428194.2026.2704265.

    PMID: 42518275
  89. 89

    Inborn Errors of Immunity and Hematopoietic Cell Transplantation: Recognition and Pretransplant Management.

    Greenwell AM, Gupte A, Al-Antary ET

    Pediatric annals 2026; (55(9)):e341-e349 doi:10.3928/19382359-20260628-02.

    PMID: 42692989